Ajooni Biotech Balance Sheet Health
Financial Health criteria checks 5/6
Ajooni Biotech has a total shareholder equity of ₹861.2M and total debt of ₹22.0M, which brings its debt-to-equity ratio to 2.5%. Its total assets and total liabilities are ₹891.0M and ₹29.7M respectively. Ajooni Biotech's EBIT is ₹23.0M making its interest coverage ratio -3.7. It has cash and short-term investments of ₹170.2M.
Key information
2.5%
Debt to equity ratio
₹21.96m
Debt
| Interest coverage ratio | -3.7x |
| Cash | ₹170.18m |
| Equity | ₹861.24m |
| Total liabilities | ₹29.72m |
| Total assets | ₹890.96m |
Recent financial health updates
No updates
Recent updates
What Ajooni Biotech Limited's (NSE:AJOONI) P/E Is Not Telling You
Jan 02
Ajooni Biotech (NSE:AJOONI) May Have Issues Allocating Its Capital
Oct 11Ajooni Biotech Limited (NSE:AJOONI) Stock Rockets 28% As Investors Are Less Pessimistic Than Expected
Sep 04Ajooni Biotech Limited's (NSE:AJOONI) 27% Share Price Surge Not Quite Adding Up
Jul 12Market Cool On Ajooni Biotech Limited's (NSE:AJOONI) Earnings Pushing Shares 25% Lower
Mar 20We Ran A Stock Scan For Earnings Growth And Ajooni Biotech (NSE:AJOONI) Passed With Ease
Nov 10We Ran A Stock Scan For Earnings Growth And Ajooni Biotech (NSE:AJOONI) Passed With Ease
Jul 13If You Like EPS Growth Then Check Out Ajooni Biotech (NSE:AJOONI) Before It's Too Late
Feb 16Should Weakness in Ajooni Biotech Limited's (NSE:AJOONI) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Feb 14
Did Ajooni Biotech Limited (NSE:AJOONI) Insiders Buy Up More Shares?
Dec 24Financial Position Analysis
Short Term Liabilities: AJOONI's short term assets (₹714.3M) exceed its short term liabilities (₹6.5M).
Long Term Liabilities: AJOONI's short term assets (₹714.3M) exceed its long term liabilities (₹23.3M).
Debt to Equity History and Analysis
Debt Level: AJOONI has more cash than its total debt.
Reducing Debt: AJOONI's debt to equity ratio has reduced from 19.2% to 2.5% over the past 5 years.
Debt Coverage: AJOONI's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: AJOONI earns more interest than it pays, so coverage of interest payments is not a concern.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/23 14:29 |
| End of Day Share Price | 2025/01/23 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Ajooni Biotech Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|